BRIEF-Aptose provides update on FDA clinical hold of APTO-253

Thu Oct 13, 2016 7:19am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Oct 13 (Reuters) - Aptose Biosciences Inc :

* Aptose provides update on FDA clinical hold of APTO-253

* Aptose biosciences-FDA response focused exclusively on request to provide with complete CMC information on final GMP drug substance and drug product intended for clinic

* Generation of additional data requested by FDA is underway, and once available data will be submitted for FDA review Source text for Eikon: Further company coverage: